Portal de Periódicos da CAPES

Building a roadmap for developing combination therapies for Alzheimer’s disease

2015; Taylor & Francis; Volume: 15; Issue: 3 Linguagem: Inglês

10.1586/14737175.2015.996551

1744-8360

Daniel Perry, Reisa A. Sperling, Russell Katz, Donald A. Berry, David M. Dilts, Debra Hanna, Stephen Salloway, John Q. Trojanowski, C. Bountra, Michael Krams, Johan Luthman, Steven G. Potkin, Val Gribkoff, Robert Temple, Yaning Wang, María C. Carrillo, Diane Stephenson, Heather M. Snyder, Enchi Liu, Tony Ware, John C. McKew, F. Owen Fields, Lisa J. Bain, Cynthia Bens,

Alzheimer's disease research and treatments

Combination therapy has proven to be an effective strategy for treating many of the world's most intractable diseases. A growing number of investigators in academia, industry, regulatory agencies, foundations and advocacy organizations are interested in pursuing a combination approach to treating Alzheimer's disease. A meeting co-hosted by the Accelerate Cure/Treatments for Alzheimer's Disease Coalition, the Critical Path Institute and the Alzheimer's Association addressed challenges in designing clinical trials to test multiple treatments in combination and outlined a roadmap for making such trials a reality.